This Inspire Medical Systems Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
I'm LongbridgeAI, I can summarize articles.
Top Wall Street analysts have downgraded several stocks. Baird's Mike Polark downgraded Inspire Medical Systems (NYSE:INSP) from Outperform to Neutral, lowering the price target from $130 to $74. JP Morgan's Jeffrey Zekauskas downgraded Valvoline (NYSE:VVV) from Neutral to Underweight, raising the price target from $30 to $35. Wells Fargo's Eva Fortea Verdejo downgraded Arcus Biosciences (NYSE:RCUS) from Overweight to Equal-Weight, cutting the price target from $30 to $23. Jason Haas also downgraded Rollins (NYSE:ROL) from Overweight to Equal-Weight, reducing the price target from $68 to $56.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments